Key Points
- Claritev SVP Tiffani Misencik sold 5,812 shares at an average price of $23.81, generating $138,383.72. The Rule 10b5-1 transaction reduced her direct ownership by 5.11% to 107,917 shares.
- Claritev shares fell 7.5% to $22.06, with the stock trading well below its 50-day moving average of $31.65. The company has a market capitalization of approximately $373.9 million and a 52-week range of $11.50 to $73.68.
- Analysts remain broadly optimistic, giving Claritev a consensus “Moderate Buy” rating and an average price target of $44.83, while institutional investors own 87.15% of the company.
Claritev (NYSE:CTEV - Get Free Report) SVP Tiffani Misencik sold 5,812 shares of the stock in a transaction on Thursday, October 15th. The stock was sold at an average price of $23.81, for a total transaction of $138,383.72. Following the completion of the sale, the senior vice president directly owned 107,917 shares of the company's stock, valued at approximately $2,569,503.77. This trade represents a 5.11% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Tiffani Misencik also recently made the following trade(s):
- On Friday, August 14th, Tiffani Misencik sold 8,850 shares of Claritev stock. The shares were sold at an average price of $40.07, for a total transaction of $354,619.50.
Claritev Trading Down 7.5%
Shares of CTEV traded down $1.80 during trading hours on Friday, reaching $22.06. 190,576 shares of the stock traded hands, compared to its average volume of 189,876. The company has a market cap of $373.92 million, a P/E ratio of -1.30 and a beta of 0.93. The company's 50-day moving average price is $31.65 and its two-hundred day moving average price is $27.55. Claritev has a 52-week low of $11.50 and a 52-week high of $73.68.
Claritev (NYSE:CTEV - Get Free Report) last issued its quarterly earnings results on Friday, August 7th. The company reported $1.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($4.10) by $5.51. The business had revenue of $257.48 million during the quarter. On average, research analysts forecast that Claritev will post -15.13 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently weighed in on the company. Wall Street Zen raised Claritev from a "sell" rating to a "hold" rating in a research note on Saturday, August 8th. Barclays reissued an "overweight" rating and set a $40.00 target price (up from $28.00) on shares of Claritev in a research note on Thursday, August 20th. Piper Sandler reissued an "overweight" rating and issued a $73.00 price target on shares of Claritev in a report on Wednesday, August 12th. Wells Fargo & Company upped their price target on Claritev from $22.00 to $30.00 and gave the stock an "equal weight" rating in a research note on Wednesday, August 12th. Finally, Canaccord Genuity Group upped their price target on Claritev from $37.00 to $43.00 and gave the stock a "buy" rating in a research note on Monday, August 10th. Six equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $44.83.
Check Out Our Latest Stock Report on Claritev
Hedge Funds Weigh In On Claritev
Institutional investors have recently bought and sold shares of the stock. Arini Captial Management Ltd bought a new stake in Claritev in the 4th quarter valued at $64,291,000. Public Investment Fund purchased a new stake in Claritev in the 2nd quarter worth $43,703,438. RBF Capital LLC boosted its holdings in shares of Claritev by 0.8% during the 1st quarter. RBF Capital LLC now owns 135,314 shares of the company's stock valued at $2,211,000 after purchasing an additional 1,127 shares during the last quarter. Bank of America Corp DE boosted its holdings in shares of Claritev by 146.6% during the 1st quarter. Bank of America Corp DE now owns 97,795 shares of the company's stock valued at $1,598,000 after purchasing an additional 58,133 shares during the last quarter. Finally, FAS Wealth Partners Inc. boosted its holdings in shares of Claritev by 49.5% during the 1st quarter. FAS Wealth Partners Inc. now owns 46,477 shares of the company's stock valued at $759,000 after purchasing an additional 15,380 shares during the last quarter. 87.15% of the stock is owned by hedge funds and other institutional investors.
About Claritev
(
Get Free Report)
Claritev is a healthcare technology, data and insights company focused on improving affordability, transparency and quality. Led by deeply experienced associates, data scientists, and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources from over 40 years of claims repricing. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
